Market Place
Sourcing Support
Immunocore Reveals 2025 Financial Results And Business Update
25 Feb 2026 //
GLOBENEWSWIRE
Moderna CMO Steps Down In Leadership Mix-Up—Chutes & Ladders
06 Feb 2026 //
FIERCE BIOTECH
Immunocore to present at upcoming investor conferences
02 Apr 2025 //
GLOBENEWSWIRE
Immunocore reports Q4 and full year 2024 financial results
26 Feb 2025 //
GLOBENEWSWIRE
Immunocore Reveals Strategic Priorities At J.P. Morgan Conference
10 Jan 2025 //
GLOBENEWSWIRE
Immunocore Appoints Travis Coy as CFO & Corporate Development
02 Jan 2025 //
GLOBENEWSWIRE
EORTC & Immunocore Enroll 1st Patient in Uveal Melanoma Trial
11 Dec 2024 //
GLOBENEWSWIRE
Immunocore announces transition of Chief Financial Officer
29 Aug 2024 //
GLOBENEWSWIRE
Immunocore Reports Q2 Financial Results And Provides Business Update
08 Aug 2024 //
GLOBENEWSWIRE
Immunocore Randomizes First Patient In Phase 3 Trial For Brenetafusp In Melanoma
18 Jun 2024 //
GLOBENEWSWIRE
KIMMTRAK Data: SD/Tumor Reduction Similar To Partial Response Outcomes
01 Jun 2024 //
GLOBENEWSWIRE
Immunocore`s Brenetafusp Data In Pretreated Melanoma At ASCO 2024
31 May 2024 //
GLOBENEWSWIRE
Immunocore to present at the Jefferies Global Healthcare Conference
30 May 2024 //
GLOBENEWSWIRE
Immunocore Converts TEBE-AM To Registrational Phase 3 In Melanoma
29 May 2024 //
GLOBENEWSWIRE
Immunocore Q1 2024 Results, Business Update
08 May 2024 //
GLOBENEWSWIRE
Immunocore announces upcoming presentation and posters at ASCO 2024
24 Apr 2024 //
GLOBENEWSWIRE
Immunocore to Present at Upcoming Investor Conferences
04 Apr 2024 //
GLOBENEWSWIRE
Immunocore presented two posters at CROI 2024
05 Mar 2024 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
01 Mar 2024 //
GLOBENEWSWIRE
Immunocore reports fourth quarter and full year 2023 financial results
28 Feb 2024 //
GLOBENEWSWIRE
Immunocore announces clinical trial collaboration and supply agreement with BMS
22 Feb 2024 //
GLOBENEWSWIRE
Immunocore to report fourth quarter and full year 2023 financial results
21 Feb 2024 //
GLOBENEWSWIRE
Immunocore Prices Upsized Convertible Senior Notes Offering
30 Jan 2024 //
GLOBENEWSWIRE
Immunocore Announces Proposed Convertible Senior Notes Offering
29 Jan 2024 //
GLOBENEWSWIRE
Immunocore announces strategic priorities and pipeline expansion
05 Jan 2024 //
GLOBENEWSWIRE
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
Immunocore announces upcoming poster presentations at SITC
01 Nov 2023 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
30 Oct 2023 //
GLOBENEWSWIRE
Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates
26 Oct 2023 //
NASDAQ
Immunocore presents three-year overall survival data from KIMMTRAK Phase 3 trial
21 Oct 2023 //
GLOBENEWSWIRE
Immunocore announces upcoming presentation and posters at ESMO 2023
06 Oct 2023 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
11 Sep 2023 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
01 Sep 2023 //
GLOBENEWSWIRE
Immunocore Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
PRESS RELEASE
Immunocore to report second quarter 2023 financial results
03 Aug 2023 //
PRESS RELEASE
Immunocore to present at upcoming investor conferences
01 Jun 2023 //
GLOBENEWSWIRE
Immunocore Reports 1Q 2023 FYR and Provides Business Update
10 May 2023 //
PRESS RELEASE
Immunocore to present at the Bank of America Securities 2023 Health Conference
03 May 2023 //
GLOBENEWSWIRE
Immunocore Holdings plc`s (NASDAQ:IMCR) Share Price Not Quite Adding Up
17 Apr 2023 //
FINANCE YAHOO
Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 //
GLOBENEWSWIRE
Immunocore to present four posters at AACR Annual Meeting 2023
14 Mar 2023 //
PRESS RELEASE
Immunocore to present at upcoming investor conferences
28 Feb 2023 //
GLOBENEWSWIRE
Immunocore to Report Fourth Quarter and Full Year 2022 Earnings
23 Feb 2023 //
GLOBENEWSWIRE
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data
22 Feb 2023 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
01 Feb 2023 //
GLOBENEWSWIRE
Immunocore announces priorities including pipeline expansion for 2023 -2024
09 Jan 2023 //
GLOBENEWSWIRE
Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 //
GLOBENEWSWIRE
Immunocore is awarded the Prix Galien France award for KIMMTRAK
15 Dec 2022 //
GLOBENEWSWIRE
Immunocore presents ovarian cancer expansion data for ImmTAC® IMC-C103C
08 Dec 2022 //
GLOBENEWSWIRE
Immunocore to present at the 5th Annual Evercore ISI HealthCONx Conference
23 Nov 2022 //
PRESS RELEASE
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn)
11 Nov 2022 //
GLOBENEWSWIRE
Immunocore to present at the Jefferies London Healthcare Conference
10 Nov 2022 //
GLOBENEWSWIRE
Immunocore Reports Third Quarter 2022 Financial Results
09 Nov 2022 //
PRESS RELEASE
GSK deals cell therapy another setback
25 Oct 2022 //
EVALUATE
GSK deals cell therapy another setback
25 Oct 2022 //
EVALUATE
Immunocore presents Phase 1 data for TCR therapy targeting PRAME
09 Sep 2022 //
PRESS RELEASE
Immunocore To Present At ESMO On Sep.9
06 Sep 2022 //
NASDAQ
Immunocore Reports Q2 Financial Results and Provides Business Update
10 Aug 2022 //
GLOBENEWSWIRE
